Who are Anesthetic Topical Adhesive Synera's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Prilocaine (Hyperbaric 2%), Ropivacaine 0.2% for PENG Block, ropivacaïne 0,5 %, Intra-articular Lidocaine, Instillation - EXPAREL, Levobupivacaine epidural bolus.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/anesthetic-topical-adhesive-synera.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Anesthetic Topical Adhesive Synera — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anesthetic Topical Adhesive Synera (Anesthetic Topical Adhesive Synera) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Topical local anesthetic. Area: Anesthesia/Pain Management.

marketed Topical local anesthetic Voltage-gated sodium channels Anesthesia/Pain Management Small molecule Live · refreshed every 30 min

Target snapshot

Anesthetic Topical Adhesive Synera (Anesthetic Topical Adhesive Synera) — Brown, Theodore R., M.D., MPH. Synera is a topical anesthetic patch that delivers lidocaine and tetracaine through the skin to numb the area before minor procedures.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Anesthetic Topical Adhesive Synera TARGET	Anesthetic Topical Adhesive Synera	Brown, Theodore R., M.D., MPH	marketed	Topical local anesthetic	Voltage-gated sodium channels
Prilocaine (Hyperbaric 2%)	Prilocaine (Hyperbaric 2%)	Guy's and St Thomas' NHS Foundation Trust	marketed	Local anesthetic	Voltage-gated sodium channels
Ropivacaine 0.2% for PENG Block	Ropivacaine 0.2% for PENG Block	Poznan University of Medical Sciences	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
ropivacaïne 0,5 %	ropivacaïne 0,5 %	Nantes University Hospital	marketed	Local anesthetic (amide)	Voltage-gated sodium channels
Intra-articular Lidocaine	Intra-articular Lidocaine	University of Central Florida	marketed	Local anesthetic	Voltage-gated sodium channels
Instillation - EXPAREL	Instillation - EXPAREL	Pacira Pharmaceuticals, Inc	marketed	Long-acting local anesthetic	Voltage-gated sodium channels
Levobupivacaine epidural bolus	Levobupivacaine epidural bolus	University of Genova	marketed	Local anesthetic (amino amide)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Topical local anesthetic class)

American University of Beirut Medical Center · 1 drug in this class
Brown, Theodore R., M.D., MPH · 1 drug in this class
Eugene Y Rhee, MD · 1 drug in this class
IWK Health Centre · 1 drug in this class
The University of Texas Health Science Center, Houston · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anesthetic Topical Adhesive Synera — Competitive Intelligence Brief. https://druglandscape.com/ci/anesthetic-topical-adhesive-synera. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab